Longer-Term DME Data Bolster Optimism Around Mechanism For Unity’s UBX1325

 
• By Alaric DeArment
  
Unity announced Phase IIa follow-up data in diabetic macular edema for UBX1325 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D